Diphtheria Toxoid Vaccine is indicated for the active immunization against diphtheria in individuals of all ages. It is administered as part of routine childhood immunization schedules and may also be given to adults as booster doses to maintain immunity.

Diphtheria

• The recommended dosage and administration schedule may vary depending on the specific vaccine formulation and age of the individual.
• Follow the guidelines provided by healthcare providers or follow the schedule recommended by public health authorities.

Adverse reactions are listed in order of decreasing frequency:

• Local reactions at the injection site (e.g., redness, swelling, pain)
• Low-grade fever
• Mild fatigue or malaise
• Headache
• Nausea
• Abnormal crying
• Erythema

Pain at injection site

Fever

Headache

Erythema

• Allergic Reactions: Individuals with a history of severe allergic reactions to a previous dose or any component of the vaccine should not receive further doses.
• Syncope: Syncope (fainting) may occur after vaccination. Individuals should be observed for 15 minutes post-vaccination.
• Adverse Events Reporting: Healthcare providers should report any adverse events following vaccination to the appropriate health authorities for monitoring and surveillance.
• Immunocompromised Individuals: The vaccine may be less effective in individuals with compromised immune systems.
• Persons previously diagnosed with Guillain-Barré syndrome (GBS) may be at increased risk of GBS following receipt of the vaccine. The decision to give the vaccine should take into account the potential benefits and risks